The evolving landscape of Plasmodium falciparum necessitates a dynamic approach to management guidelines. Current recommendations, often guided by the World Health Organization Authority, prioritize the use of artemisinin-based combination treatments (ACTs) as first-line management in most endemic regions. However, the rise of artemisinin immunity

A cutting-edge drug is generating hope in the medical community, as it shows remarkable results for both weight loss and diabetes management. In ongoing clinical trials, individuals taking the medication experienced significant reductions in body weight. Moreover, the drug also demonstrated positive effects in blood sugar control for patients with